ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1274

Rheumatoid Arthritis Patients, Achieving Low Disease Activity State or Remission, Still Demonstrate Significant Hand Disability, as Assessed by Functional Dexterity Test: A Disconnection Between CDAI and Functional Hand Assessment

Aniela Shouval1, Amihai Levkovitch2, Itzhak Rosner3, shiri keret4, Irina Rokhyan2, Boris Tchalabian2, Esther Hof5 and Gleb Slobodin6, 1Bnai Zion Medical Center, Haifa, Israel, 2Department of Rehabilitation, Bnai Zion Medical Center, Haifa, Israel, 3Bnai Zion Medical Center/Technion, Haifa, Israel, 4Bnai Zion, Atlit, Israel, 5Occupational Therapy Unit, Bnai zion Medical Center, Haifa, Israel, 6Rheumatology Unit, Bnai Zion Medical Center, Haifa, Israel

Meeting: ACR Convergence 2023

Keywords: Disease Activity, functional status, hand, Occupational therapy, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (1264–1307) RA – Diagnosis, Manifestations, and Outcomes Poster II

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Direct functionality of the hand is not commonly assessed in daily practice or clinical trials in patients with rheumatoid arthritis (RA). Functional dexterity test (FDT), developed to assess a patient’s ability to use the hand for daily tasks and widely used in rehabilitation medicine, has also been suggested as a legitimate tool for RA patients [Aaron et al, J Hand Ther. 2003]. Aim: To examine the value of FDT in a cohort of RA patients and to study the correlation between the results of FDT and RA activity.

Methods: Patients with established RA were followed in the outpatient clinic of Bnai Zion Medical Center performed the FDT during their regular follow-up visits. All patients were given 100 seconds (sec) to complete the test; the performance was measured in seconds separately for the dominant and non-dominant hands. FDT results were compared among 28 patients with active RA and clinical disease activity index(CDAI) greater than 10, 20 RA patients with controlled disease activity (CDAI of less than or equal to 10), and 20 volunteers with no rheumatic disease from the hospital personnel who agreed to perform the FDT.

Results: A group of patients with active RA was younger than other groups, with a median age of 56 years (range 30-88 years) vs. 65 years (range 41-78 years) in the controlled RA group vs. 62 years (range 40-82 years) in the control group, p < 0.03. The mean disease duration was 11 years (range 3-26 years) in the active disease group and 11 years (range 1-47 years) in the controlled RA group, p=0.97. The gender composition of the groups was similar, with female patients comprising 70% to 82% (p=0.67). All 28 RA patients with CDAI >10 and 16 of 20 patients with CDAI< or equal to 10 were treated with biologics (p=0.02). Mean FDT for the dominant hand was 43 sec (range 24-100 sec) in the active RA group, 35 sec (range 27-70 sec) in the controlled RA group, and 25 sec (range 20-40 sec) in persons without arthritis. Corresponding FDT results for the non-dominant hand were 50 sec (range 22-100 sec), 38 sec (range 24-68 sec), and 29 sec (22-45 sec), respectively (Table 1). The difference in the FDT results between the two RA groups was non-significant for the dominant hand (p=0.28) but reached statistical significance for the non-dominant hand (p=0.02). Individuals without arthritis performed FDT either by dominant or non-dominant hand significantly better than any RA group (p values from 0.013 to 0.0001). FDT results significantly correlated with CDAI in the group of active RA only, with R=0.47/p=0.01 for the dominant hand and R=0.49/p=0.007 for the non-dominant hand vs. R=0.29/p=0.2, and R=0.4/p=0.08, respectively, in the controlled RA group. Minimally or non-functioning dominant hand, as predefined by FDT, was observed in 17 of 28 patients with active RA (61%), 11 of 20 patients (55%) with controlled disease, and 3 of 20 (15%) volunteers with no rheumatic disease.

Conclusion: FDT revealed a significant decrease in hand function in most RA patients. In patients with high or moderate RA activity, FDT correlated well with CDAI scores, while this correlation was lost in the group of patients with low disease activity or remission, where 55% of patients still demonstrated a significant loss in the dominant hand function.

Supporting image 1

Table 1. Corresponding FDT results for the dominant and non-dominant hand


Disclosures: A. Shouval: None; A. Levkovitch: None; I. Rosner: None; s. keret: None; I. Rokhyan: None; B. Tchalabian: None; E. Hof: None; G. Slobodin: None.

To cite this abstract in AMA style:

Shouval A, Levkovitch A, Rosner I, keret s, Rokhyan I, Tchalabian B, Hof E, Slobodin G. Rheumatoid Arthritis Patients, Achieving Low Disease Activity State or Remission, Still Demonstrate Significant Hand Disability, as Assessed by Functional Dexterity Test: A Disconnection Between CDAI and Functional Hand Assessment [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/rheumatoid-arthritis-patients-achieving-low-disease-activity-state-or-remission-still-demonstrate-significant-hand-disability-as-assessed-by-functional-dexterity-test-a-disconnection-between-cdai/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rheumatoid-arthritis-patients-achieving-low-disease-activity-state-or-remission-still-demonstrate-significant-hand-disability-as-assessed-by-functional-dexterity-test-a-disconnection-between-cdai/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology